Thermo Fisher Scientific Pre-Tax Profit Margin 2010-2022 | TMO

Current and historical pre-tax profit margin for Thermo Fisher Scientific (TMO) from 2010 to 2022. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Thermo Fisher Scientific pre-tax profit margin for the three months ending December 31, 2022 was .
Thermo Fisher Scientific Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2022-12-31 $44.92B $7.84B 17.44%
2022-09-30 $44.17B $7.92B 17.93%
2022-06-30 $42.82B $8.50B 19.84%
2022-03-31 $41.12B $8.63B 20.98%
2021-12-31 $39.21B $8.84B 22.55%
2021-09-30 $39.06B $9.88B 25.28%
2021-06-30 $38.25B $9.95B 26.02%
2021-03-31 $35.89B $9.16B 25.51%
2020-12-31 $32.22B $7.23B 22.44%
2020-09-30 $28.50B $5.37B 18.85%
2020-06-30 $26.25B $3.94B 15.02%
2020-03-31 $25.65B $4.08B 15.92%
2019-12-31 $25.54B $4.07B 15.94%
2019-09-30 $25.22B $4.04B 16.03%
2019-06-30 $24.87B $4.03B 16.21%
2019-03-31 $24.63B $3.45B 13.99%
2018-12-31 $24.36B $3.26B 13.39%
2018-09-30 $23.90B $3.07B 12.85%
2018-06-30 $23.09B $2.74B 11.86%
2018-03-31 $22.01B $2.56B 11.63%
2017-12-31 $20.92B $2.43B 11.61%
2017-09-30 $19.82B $2.26B 11.41%
2017-06-30 $19.20B $2.21B 11.51%
2017-03-31 $18.74B $2.10B 11.22%
2016-12-31 $18.27B $2.02B 11.08%
2016-09-30 $17.97B $1.95B 10.87%
2016-06-30 $17.61B $1.99B 11.33%
2016-03-31 $17.34B $1.98B 11.40%
2015-12-31 $16.97B $1.94B 11.41%
2015-09-30 $16.81B $1.89B 11.25%
2015-06-30 $16.85B $1.96B 11.64%
2015-03-31 $16.91B $1.70B 10.03%
2014-12-31 $16.89B $2.09B 12.36%
2014-09-30 $15.86B $1.93B 12.15%
2014-06-30 $14.89B $1.71B 11.47%
2014-03-31 $13.80B $1.75B 12.69%
2013-12-31 $13.09B $1.32B 10.08%
2013-09-30 $12.88B $1.29B 9.98%
2013-06-30 $12.78B $1.26B 9.88%
2013-03-31 $12.65B $1.30B 10.29%
2012-12-31 $12.51B $1.27B 10.14%
2012-09-30 $12.30B $1.24B 10.06%
2012-06-30 $12.15B $1.21B 9.94%
2012-03-31 $11.90B $1.15B 9.63%
2011-12-31 $11.56B $1.13B 9.80%
2011-09-30 $11.05B $1.10B 9.95%
2011-06-30 $10.75B $1.12B 10.43%
2011-03-31 $10.49B $1.13B 10.75%
2010-12-31 $10.39B $1.09B 10.47%
2010-09-30 $10.49B $1.04B 9.93%
2010-06-30 $10.40B $1.00B 9.64%
2010-03-31 $10.28B $0.97B 9.46%
2009-12-31 $9.91B $0.88B 8.88%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $230.517B $44.915B
Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions Segment, Analytical Instruments, and Specialty Diagnostics.
Stock Name Country Market Cap PE Ratio
Edwards Lifesciences (EW) United States $50.772B 33.11
Alcon (ALC) Switzerland $37.369B 32.17
STERIS (STE) Ireland $21.864B 27.21
Teleflex (TFX) United States $12.124B 19.67
Fresenius Medical Care AG KGaA (FMS) Germany $11.123B 11.16
Penumbra (PEN) United States $9.913B 2372.91
Globus Medical (GMED) United States $7.950B 40.42
Glaukos (GKOS) United States $2.458B 0.00
Integer Holdings (ITGR) United States $2.435B 19.55
AVANOS MEDICAL, INC (AVNS) United States $1.469B 20.92
Nevro (NVRO) United States $1.410B 0.00
Paragon 28 (FNA) United States $1.346B 0.00
Artivion (AORT) United States $0.566B 0.00